Clinical Trials · NCT01374087

Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer

Name: Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

TerminatedPhase 2Gonadorelin

Phase: Phase 2
Recruitment status: Terminated
Sponsor: Ipsen
Enrollment: 32
Start date: Nov 2011
Locations: 11 sites, Spain
Primary endpoint: Biochemical Failure-free Survival (BFFS)

View Gonadorelin compound reference